Orthofix International Announces the Launch of the CONSTRUX® Mini PEEK
Titanium Composite™ (PTC) Spacer System
LEWISVILLE, Texas -- January 9, 2013
Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today the
launch of the CONSTRUX^® Mini PEEK Titanium Composite^™ (PTC) Spacer System
through its spine distribution network. This anterior cervical interbody
system incorporates a unique technology that combines the benefits of PEEK’s
imaging capabilities with the potential of bone ingrowth from porous titanium
Dr. Scott Stanley, Medical Director of the Spine Program at Parker Adventist
Hospital in Parker, Colorado, who is the primary surgeon innovator behind the
technology stated, "After years of hard work in this product's development, I
am thrilled to utilize this implant for my patients. I believe that the porous
interface will allow for potential bone ingrowth as demonstrated in the
orthopedic joint arthroplasty literature. This product will allow patients to
return to extracurricular activities and activities of daily living in a
The CONSTRUX^® Mini PEEK Titanium Composite^™ (PTC) Spacer System has porous
titanium endplates that provide a 3D porous material with the potential for
bone ingrowth that may create a bond between the bone and the implant. The
implant also features a PEEK core, which allows for post and intraoperative
imaging without the severe image distortion associated with metal designs
currently on the market.
“We are very excited about the launch of this novel, differentiated cervical
interbody system. It represents the beginning of a series of product launches
in 2013 that will bring our cervical implant product offering to the forefront
of the industry,” said President and Chief Executive Officer Robert Vaters.
This PEEK/ Titanium hybrid offers three footprints and various heights to
address the cervical interbody fusion solution. These implants work with the
CONSTRUX Mini PEEK Spacer System instrument trays currently in the field.
Orthofix International N.V. is a diversified, global medical device company
focused on developing and delivering innovative repair and regenerative
solutions to the spine and orthopedic markets. Orthofix’s products are widely
distributed around the world to surgeons and patients via Orthofix’s sales
representatives and its subsidiaries, and via collaborations with other
leading orthopedic product companies. In addition, Orthofix is collaborating
on R&D activities with leading research and clinical organizations such as the
Musculoskeletal Transplant Foundation, the Orthopedic Research and Education
Foundation, and Texas Scottish Rite Hospital for Children. For more
information about Orthofix, please visit www.orthofix.com.
Mark Quick, 214-937-2924
Director of Investor Relations and Business Development
Press spacebar to pause and continue. Press esc to stop.